SNO

DRUG2 trials

Sponsors

James Reynolds

Conditions

Covid19SARS-CoV2 InfectionTransfusion Related Complication

Early Phase 1

S-Nitrosylation Therapy of COVID-19

WithdrawnNCT04528771

James ReynoldsCovid19, SARS-CoV2 Infection

Start: 2021-08-05End: 2025-04-30Updated: 2025-05-07

Phase 1

S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion

RecruitingNCT03999229

James ReynoldsTransfusion Related Complication

Start: 2019-07-25End: 2028-02-29Target: 35Updated: 2025-12-02